AbbVie Inc. ABBV
Loading live quote…
$224.77
-0.18
(-0.08%)
Price Chart
About AbbVie
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox Cosmetic for the treatment of glabellar lines, crow's…
Recent Quarters
| Quarter | Revenue | Net Income | EPS (dil.) | Gross Margin |
|---|---|---|---|---|
| 2026 Q1 | — | $695.0M | 0.39 | 71.9% |
| 2025 Q4 | — | $1.82B | 1.02 | 72.6% |
| 2025 Q3 | — | $186.0M | 0.10 | 66.4% |
| 2025 Q2 | — | $938.0M | 0.52 | 71.8% |


